abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Operating Cash Flow Growth
-16.71%
Quarterly · Period ending:
HQL Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-16.71%period ending
Latest reported-16.71%period ending
HQL Quarterly Cash from Operations YoY % (0.00% → -16.71%)
Year-over-year change
High-resolution chart · PNG
HQL operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -16.707% | |
| 100% | |
| 100% | |
| 100% | |
| 100% | |
| 100% | |
| -100% | |
| 21.8437% | |
| 657.4012% | |
| -1,255.4909% | |
| 174.9497% | |
| -99.8766% | |
| -99.9871% | |
| -93.0493% | |
| -71.2701% | |
| 6,126.3158% | |
| 6,126.3158% | |
| -85.3846% | |
| -85.3846% | |
| 10.1695% | |
| 10.1695% | |
| 418.9189% | |
| 418.9189% | |
| -76.1905% | |
| -76.1905% | |
| 34.375% | |
| 34.375% | |
| 0% | |
| 0% | |
| -33.3333% | |
| -33.3333% | |
| 7.6923% | |
| 7.6923% | |
| -36.8421% | |
| -36.8421% | |
| -133.3333% | |
| 106.6667% | |
| 0% | |
| 0% |